GlassScriptPhysician profile
Sonia Samtani
NPI 1548526080
$17,134.17
in general payments reported to CMS, 2019-2025
38 companies · $3,834 in 2025
The $3,834 reported for 2025 was more than what 79% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,025 · 2020: $482 · 2021: $913 · 2022: $4,465 · 2023: $2,122 · 2024: $3,293 · 2025: $3,834.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,063 · Travel and Lodging: $3,079 · Education: $106.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,063.18 |
| Travel and Lodging | $3,079.36 |
| Education | $106.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,139.52 | 2021-2025 | Onyx Frontier, Symplicity G3, Resolute Onyx |
| Abbott Laboratories | $2,941.45 | 2019-2025 | Optis, Dragonfly Opstar, Jot Dx |
| Atricure, INC. | $1,495.12 | 2022 | |
| Teleflex LLC | $1,143.03 | 2025 | Guideliner |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $763.21 | 2019-2025 | Lifevest |
| Amgen INC. | $708.83 | 2020-2025 | Repatha, Repatha |
| Edwards Lifesciences Corporation | $665.22 | 2019-2020 | |
| Boston Scientific Corporation | $595.21 | 2021-2025 | Accolade Sr, Avvigo Guidance System, General - Atherectomy |
| Abiomed | $521.18 | 2019-2024 | Impella |
| Asahi Intecc USA, INC. | $481.94 | 2024-2025 | Asahi Coronary Wires, Asahi Peripheral Vascular Wires, Peripheral Vascular |
| Cardiovascular Systems INC. | $346.30 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $298.44 | 2019-2023 | Brilinta |
| Akcea Therapeutics, INC. | $285.61 | 2019-2020 | |
| Philips North America LLC | $259.66 | 2021-2024 | (Bq9) Coronary Ivus |
| E.R. Squibb & Sons, L.L.C. | $231.80 | 2022-2025 | Eliquis, Camzyos |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $228.01 | 2022 | |
| Cvrx, INC. | $208.41 | 2024 | Barostim Neo System |
| Merck Sharp & Dohme LLC | $201.61 | 2022-2023 | Verquvo |
| Janssen Pharmaceuticals, INC | $193.55 | 2019-2020 | |
| Medtronic Vascular, INC. | $192.74 | 2019 | |
| Verge Medical, INC. | $181.81 | 2024 | |
| Actelion Pharmaceuticals US, INC. | $144.49 | 2024 | Opsumit, Uptravi |
| Penumbra, INC. | $136.77 | 2022 | |
| Esperion Therapeutics, INC. | $122.05 | 2021 | |
| Novartis Pharmaceuticals Corporation | $105.45 | 2022-2023 | |
| Glaxosmithkline, LLC. | $75.80 | 2022 | |
| Cook Medical LLC | $72.79 | 2023-2025 | Zilver Ptx |
| Terumo Medical Corporation | $67.30 | 2019-2023 | Navicross, Glidewire, Angio-Seal |
| Kestra Medical Technology Services, INC. | $62.38 | 2025 | Assure Wcd |
| Shockwave Medical, INC | $59.85 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Novo Nordisk INC | $50.00 | 2025 | Wegovy |
| Scpharmaceuticals INC. | $27.70 | 2024 | |
| Cagent Vascular INC | $24.38 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.27 | 2023 | Jardiance |
| Pfizer INC. | $21.21 | 2024 | |
| Cordis US Corp. | $20.16 | 2023 | Mynxgrip |
| W. L. Gore & Associates, INC. | $19.64 | 2023 | Gore Viabahn Vbx Balloon Expandable Endo |
| Chiesi USA, INC. | $17.28 | 2025 | Kengreal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonia Samtani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.